Allan E. Rubenstein

2.4k total citations
34 papers, 1.0k citations indexed

About

Allan E. Rubenstein is a scholar working on Neurology, Molecular Biology and Rheumatology. According to data from OpenAlex, Allan E. Rubenstein has authored 34 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Neurology, 8 papers in Molecular Biology and 7 papers in Rheumatology. Recurrent topics in Allan E. Rubenstein's work include Neurofibromatosis and Schwannoma Cases (17 papers), Neuroblastoma Research and Treatments (6 papers) and Soft tissue tumor case studies (4 papers). Allan E. Rubenstein is often cited by papers focused on Neurofibromatosis and Schwannoma Cases (17 papers), Neuroblastoma Research and Treatments (6 papers) and Soft tissue tumor case studies (4 papers). Allan E. Rubenstein collaborates with scholars based in United States, Brazil and France. Allan E. Rubenstein's co-authors include Karen Stephens, David Viskochil, Bruce R. Korf, Graham Davis, Stephen M. Collins, D. Baetens, J. Michael Conlon, D M McCarthy, Mariella Ravazzola and David H. Gutmann and has published in prestigious journals such as New England Journal of Medicine, SHILAP Revista de lepidopterología and Neurology.

In The Last Decade

Allan E. Rubenstein

32 papers receiving 969 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Allan E. Rubenstein United States 17 658 387 250 181 149 34 1.0k
Mitsuhiro Hara Japan 22 745 1.1× 340 0.9× 197 0.8× 171 0.9× 275 1.8× 89 1.9k
Franco Ammannati Italy 18 558 0.8× 332 0.9× 167 0.7× 130 0.7× 157 1.1× 65 998
Brien G. Benoit Canada 21 554 0.8× 193 0.5× 95 0.4× 89 0.5× 173 1.2× 41 1.1k
J F Pellissier France 20 588 0.9× 217 0.6× 438 1.8× 196 1.1× 101 0.7× 57 1.6k
Naoki Kitagawa Japan 19 352 0.5× 205 0.5× 196 0.8× 96 0.5× 164 1.1× 75 1.0k
Shanna Fang United States 18 491 0.7× 483 1.2× 137 0.5× 73 0.4× 223 1.5× 24 1.1k
F. Slowik Hungary 17 232 0.4× 187 0.5× 110 0.4× 91 0.5× 123 0.8× 44 793
Shōzō Ishii Japan 19 524 0.8× 146 0.4× 157 0.6× 51 0.3× 181 1.2× 61 1.1k
Jun Masuoka Japan 17 433 0.7× 161 0.4× 239 1.0× 88 0.5× 165 1.1× 58 902
Tomoyuki Koga Japan 20 414 0.6× 318 0.8× 266 1.1× 66 0.4× 111 0.7× 61 1.1k

Countries citing papers authored by Allan E. Rubenstein

Since Specialization
Citations

This map shows the geographic impact of Allan E. Rubenstein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Allan E. Rubenstein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Allan E. Rubenstein more than expected).

Fields of papers citing papers by Allan E. Rubenstein

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Allan E. Rubenstein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Allan E. Rubenstein. The network helps show where Allan E. Rubenstein may publish in the future.

Co-authorship network of co-authors of Allan E. Rubenstein

This figure shows the co-authorship network connecting the top 25 collaborators of Allan E. Rubenstein. A scholar is included among the top collaborators of Allan E. Rubenstein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Allan E. Rubenstein. Allan E. Rubenstein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rubenstein, Allan E., Jina Chung, & Misha Rosenbach. (2025). Granuloma annulare treated with certolizumab following the development of antidrug antibodies to adalimumab. JAAD Case Reports. 61. 154–156.
2.
Oliveira, Lisa, Mauro Geller, Karin Soares Cunha, et al.. (2021). Clinical assessment of the use of topical liquid diclofenac following laser microporation of cutaneous neurofibromas in individuals with neurofibromatosis type 1. Heliyon. 7(3). e06518–e06518. 5 indexed citations
3.
Geller, Mauro, et al.. (2020). Determination of Vitamin D Levels in Patients With Neurofibromatosis Type 1 in the Pediatric Age Group. SHILAP Revista de lepidopterología. 13. 2632010X20928930–2632010X20928930.
4.
Geller, Mauro, Lisa Oliveira, Allan E. Rubenstein, et al.. (2015). A Proof-of-Concept Assessment of the Safety and Efficacy of Intralesional Diclofenac in the Treatment of Cutaneous Neurofibromas. International Journal of Clinical Medicine. 6(12). 975–983. 4 indexed citations
5.
Tanaka, Karo, Ascia Eskin, Fabrice Chareyre, et al.. (2013). Therapeutic Potential of HSP90 Inhibition for Neurofibromatosis Type 2. Clinical Cancer Research. 19(14). 3856–3870. 28 indexed citations
6.
Tradewell, Miranda L., Benoît J. Gentil, Sandra Minotti, et al.. (2013). A novel small molecule HSP90 inhibitor, NXD30001, differentially induces heat shock proteins in nervous tissue in culture and in vivo. Cell Stress and Chaperones. 19(3). 421–435. 21 indexed citations
7.
Wang, Cuihua, Sofía Barluenga, Girish Koripelly, et al.. (2009). Synthesis of pochoxime prodrugs as potent HSP90 inhibitors. Bioorganic & Medicinal Chemistry Letters. 19(14). 3836–3840. 15 indexed citations
8.
Fishbein, Lauren, Xuelian Zhang, Hua Li, et al.. (2007). In vitro studies of steroid hormones in neurofibromatosis 1 tumors and schwann cells. Molecular Carcinogenesis. 46(7). 512–523. 36 indexed citations
9.
Korf, Bruce R. & Allan E. Rubenstein. (2005). Neurofibromatosis: A Handbook for Patients, Families, and Health Care Professionals. 17 indexed citations
10.
Packer, Roger J., David H. Gutmann, Allan E. Rubenstein, et al.. (2002). Plexiform neurofibromas in NF1. Neurology. 58(10). 1461–1470. 117 indexed citations
11.
Rubenstein, Allan E. & Bruce R. Korf. (1998). Neurofibromatose : handboek voor patiënten, familieleden en professionele begeleiders. 1 indexed citations
12.
Aylsworth, Arthur S., et al.. (1997). The diagnostic evaluation and multidisciplinary management of neurofibromatosis 1 and neurofibromatosis 2. American Journal of Ophthalmology. 124(5). 718–719. 49 indexed citations
13.
Leppig, Kathleen A., David Viskochil, Allan E. Rubenstein, et al.. (1996). The detection of contiguous gene deletions at the neurofibromatosis 1 locus with fluorescence in situ hybridization. Cytogenetic and Genome Research. 72(1). 95–98. 44 indexed citations
14.
Mindel, Joel S., Allan E. Rubenstein, Sibylle Wallace, Alan M. Aron, & John Halperin. (1994). Congenital Horner's syndrome does not alter Lisch nodule formation. Annals of Neurology. 35(1). 123–124. 1 indexed citations
15.
Sonnenfeld, Kenneth H., Paulette Bernd, Allan E. Rubenstein, & Gen Sobue. (1986). Nerve Growth Factor Binding to Cells Derived from Neurofibromasa. Annals of the New York Academy of Sciences. 486(1). 107–114. 3 indexed citations
16.
Sonnenfeld, Kenneth H., Paulette Bernd, Gen Sobue, Mark Lebwohl, & Allan E. Rubenstein. (1986). Nerve growth factor receptors on dissociated neurofibroma Schwann-like cells.. PubMed. 46(3). 1446–52. 32 indexed citations
17.
Businaro, Rita, Richard H. Butler, Allan E. Rubenstein, & Roberto P. Revoltella. (1981). Monoclonal antibodies against mouse nerve growth factor produced by somatic cell hybrids. Journal of Neuroscience Research. 6(1). 89–98. 9 indexed citations
18.
Mindel, Joel S., Allan E. Rubenstein, & Bonita Franklin. (1981). Ocular Ergotamine Tartrate Toxicity During Treatment of Vacor-Induced Orthostatic Hypotension. American Journal of Ophthalmology. 92(4). 492–496. 9 indexed citations
19.
Korczyn, Amos D., Allan E. Rubenstein, Melvin D. Yahr, & Felicia B. Axelrod. (1981). The pupil in familial dysautonomia. Neurology. 31(5). 628–628. 10 indexed citations
20.
Rubenstein, Allan E., et al.. (1979). Peripheral catecholamine depletion in amyloid autonomic neuropathy.. PubMed. 45(6). 782–9. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mitsuhiro Hara Breakdown of academic impact, for papers by Franco Ammannati Breakdown of academic impact, for papers by Brien G. Benoit Breakdown of academic impact, for papers by J F Pellissier Breakdown of academic impact, for papers by Naoki Kitagawa Breakdown of academic impact, for papers by Shanna Fang Breakdown of academic impact, for papers by F. Slowik Breakdown of academic impact, for papers by Shōzō Ishii Breakdown of academic impact, for papers by Jun Masuoka Breakdown of academic impact, for papers by Tomoyuki Koga
Rankless by CCL
2026